Construction and Identification of a Novel Bacterial Artificial Chromosome of Herpesvirus of Turkey
WANG Zhi-sheng1,3,LIU Fang1,2,XU Meng-wei1,2,QIAO Yong-feng1,3,HOU Ji-bo1,3,WANG Ji-chun1,3*
(1.National Research Center of Engineering and Technology for Veterinary Biologicals,Jiangsu Academy of Agricultural Sciences,Nanjing 210014,China;2.College of Veterinary Medicine,Nanjing Agricultural University,Nanjing 210095,China;3.Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses,Yangzhou 225009,China)
WANG Zhi-sheng,LIU Fang,XU Meng-wei,QIAO Yong-feng,HOU Ji-bo,WANG Ji-chun. Construction and Identification of a Novel Bacterial Artificial Chromosome of Herpesvirus of Turkey[J]. ACTA VETERINARIA ET ZOOTECHNICA SINICA, 2016, 47(10): 2071-2080.
[1]MELCHIOR F J,FREDRICKSON T,LUGINBUHL R.Neutralization studies with Marek’s disease virus and turkey herpesvirus[J].Appl Microbiol,1973,26(6):925-933.
[2]RAHAUS M,AUGUSTINSKI K,CASTELLS M,et al.Application of a new bivalent Marek’s disease vaccine does not interfere with infectious bronchitis or Newcastle disease vaccinations and proves efficacious[J].Avian Dis,2013,57(2 Suppl):498-502.
[3]AFONSO C,TULMAN E,LU Z,et al.The genome of turkey herpesvirus[J].J Virol,2001,75(2):971-978.
[4]SONDERMEIJER P,CLAESSENS J,JENNISKENS P,et al.Avian herpesvirus as a live viral vector for the expression of heterologous antigens[J].Vaccine,1993,11(3):349-358.
[5]TSUKAMOTO K,SAITO S,SAEKI S,et al.Complete,long-lasting protection against lethal infectious bursal disease virus challenge by a single vaccination with an avian herpesvirus vector expressing VP2 antigens[J].J Virol,2002,76(11):5637-5645.
[6]DARTEIL R,BUBLOT M,LAPLACE E,et al.Herpesvirus of turkey recombinant viruses expressing infectious bursal disease virus (IBDV) VP2 immunogen induce protection against an IBDV virulent challenge in chickens[J].Virology,1995,211(2):481-490.
[7]ESAKI M,GODOY A,ROSENBERGER J,et al.Protection and antibody response caused by turkey herpesvirus vector Newcastle disease vaccine[J].Avian Dis,2013,57(4),750-755.
[8]PALYA V,KISS I,TATÁR-KIS T,et al.Advancement in vaccination against Newcastle disease:recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions[J].Avian Dis,2012,56(2):282-287.
[9]RAUW F,PALYA V,GARDIN Y,et al.Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains[J].Avian Dis,2012,56(4 Suppl):913-922.
[10]PALYA V,TATÁR-KIS T,MATÓ T,et al.Onset and long-term duration of immunity provided by a single vaccination with a turkey herpesvirus vector ND vaccine in commercial layers[J].Vet Immunol Immunopathol,2014,158(1-2):105-115.
[11]LIU S,SUN W,CHU J,et al.Construction of recombinant HVT expressing PmpD,and immunological evaluation against chlamydia psittaci and Marek’s disease virus[J].PLoS One,2015,10(4):e0124992.
[12]PANTIN-JACKWOOD M,KAPCZYNSKI D,DEJESUS E,et al.Efficacy of a recombinant turkey herpesvirus h5 vaccine against challenge With H5N1 clades 1.1.2 and 2.3.2.1 highly pathogenic avian influenza viruses in domestic ducks (Anas platyrhynchos domesticus)[J].Avian Dis,2016,60(1):22-32.
[13]LIU J,CHEN P,JIANG Y,et al.A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus in ducks[J].J Virol,2011,85(21):10989-10998.
[14]CHEN Y,GUO W,XU Z,et al.A novel recombinant pseudorabies virus expressing parvovirus VP2 gene:Immunogenicity and protective efficacy in swine[J].Virol J,2011,8:307.
[15]兰德松,石星明,王云峰,等. 火鸡疱疹病毒细菌人工染色体的构建[J].微生物学报,2008,48(6):811-817.
LAN D S,SHI X M,WANG Y F,et al.Reconstituting turkey herpesvirus with bacterial artificial chromosome clones[J].Acta Microbiologica Sinica,2008,48(6):811-817.(in Chinese)
[16]WARDEN C,TANG Q,ZHU H.Herpesvirus BACs:past,present,and future[J].J Biomed Biotechnol,2011:124595.
[17]TISCHER B,SMITH G,OSTERRIEDER N.En passant mutagenesis:a two step markerless red recombination system[J].Methods Mol Biol,2010,634:421-430.
[18]OSTERRIEDER N,SCHUMACHER D,TRAPP S,et al.Establishment and use of infectious bacterial artificial chromosome (BAC) DNA clones of animal herpesviruses[J].Berl Munch Tierarztl Wochenschr,2003,116:373-380.
[19]MESSERLE M,CRNKOVIC I,HAMMERSCHMIDT W,et al.Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome[J].Proc Natl Acad Sci U S A,1997,94:14759-14763.
[20]OSTERRIEDER N.Construction and characterization of an equine herpesvirus 1 glycoprotein C negative mutant[J].Virus Res,1999,59:165-77.
[21]WANG J,OSTERRIEDER N.Generation of an infectious clone of duck enteritis virus and generation of a vectored DEV expressing hemagglutinin of H5N1 avian influenza virus[J].Virus Res,2011,159(1):23-31.
[22]TISCHER B,VON EINEM J,KAUFER B,et al.Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli[J].Biotechniques,2006,40:191-197.
[23]REDDY S,SUN A,KHAN O,et al.Cloning of a very virulent plus,686 strain of Marek’s disease virus as a bacterial artificial chromosome[J].Avian Dis,2013,57(2 Suppl):469-473.
[24]WANG J,GE A,XU M,et al.Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens[J].Virol J,2015,12:126.
[25]MA C,ZHANG Z,ZHAO P,et al.Comparative transcriptional activity of five promoters in BAC-cloned MDV for the expression of the hemagglutinin gene of H9N2 avian influenza virus[J].J Virol Methods,2014,206:119-127.
[26]BAIGENT S,PETHERBRIDGE L,SMITH L,et al.Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek’s disease[J].J Gen Virol,2006,87(Pt 4):769-776.
[27]HALL R,MEERS J,FOWLER E,et al.Identification of non-essential loci within the Meleagrid herpesvirus 1 genome[J].Virol J,2015,12:130.
[28]RAUW F,GARDIN Y,PALYA V,et al.The combination of attenuated Newcastle disease (ND) vaccine with rHVT-ND vaccine at 1 day old is more protective against ND virus challenge than when combined with inactivated ND vaccine[J].Avian Pathol,2014,43(1):26-36.
[29]PRANDINI F,SIMON B,JUNG A,et al.Comparison of infectious bursal disease live vaccines and a HVT-IBD vector vaccine and their effects on the immune system of commercial layer pullets[J].Avian Pathol,2016,45(1):114-125.
[30]KAPCZYNSKI D,ESAKI M,DORSEY K,et al.Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus[J].Vaccine,2015,33(9):1197-1205.
[31]ADAMIAK B,TRYBALA E,MARDBERG K,et al.Human antibodies to herpes simplex virus type 1 glycoprotein C are neutralizing and target the heparan sulfate-binding domain[J].Virology,2010,400:197-206.
[32]JAROSINSKI K,OSTERRIEDER N.Further analysis of Marek’s disease virus horizontal transmission confirms that U(L)44 (gC) and U(L)13 protein kinase activity are essential,while U(S)2 is nonessential[J].J Virol,2010,84:7911-7916.